Building A TB Laboratory Risk Matrix For Biosafety Decisions
A TB laboratory risk assessment matrix turns broad safety concerns into a documented decision about containment, controls and work practices. It helps a laboratory decide whether a procedure can be performed at physical containment level 2 (PC2), requires PC3 conditions, or should be referred to a facility with greater capability. The matrix should support professional judgement, not replace it.
For tuberculosis work, the central concern is exposure to infectious aerosols containing Mycobacterium tuberculosis complex organisms. Risks may arise during specimen reception, opening containers, preparing specimens, culture manipulation, instrument maintenance, waste handling and spill response. A useful assessment considers the whole workflow rather than assigning a level based only on the test name.
Australian laboratories also need to work within state and territory work health and safety requirements, relevant Australian Standards and local accreditation expectations. AS/NZS 2243.3 is an important reference for microbiological safety, while NATA assessment may examine whether risk decisions are evidence-based, implemented and reviewed. Requirements can differ between a metropolitan public laboratory, a private provider and a small regional service.
The matrix is especially valuable where services are distributed across Australia. A laboratory supporting communities in the Northern Territory, Western Australia or far north Queensland may receive delayed specimens, use courier networks and rely on staff with different levels of TB experience. Clear escalation criteria help teams in places such as Darwin, Alice Springs or regional New South Wales make consistent decisions without relying on informal assumptions.
Define The Work Before Rating The Risk
Start by mapping each activity from receipt to final disposal. Record the specimen type, expected organism, volume, concentration, manipulation, equipment and people involved. Include sputum, bronchoalveolar lavage, tissue, blood cultures where relevant, environmental samples and referral material. A specimen that arrives labelled “TB query” should be treated according to the credible hazards associated with its condition and handling, not simply the certainty of the diagnosis.
Separate low-aerosol activities from procedures that may generate infectious particles. Closed-system analysis, sealed transport and unopened primary containers may present a different risk from vortexing, aliquoting, centrifugation, culture manipulation or opening plates and tubes. Equipment failure, cracked containers and interruptions during processing should appear in the assessment because routine assumptions often fail during abnormal events.
The assessment team should include the laboratory manager, senior scientists, a biosafety or infection-control adviser and staff who actually perform the work. In an Australian public health service, consultation with the jurisdictional public health laboratory or work health and safety unit may be appropriate. Include cleaners, couriers and maintenance contractors where their duties bring them into contact with specimens, waste or contaminated equipment.
Use A Consistent Risk Scoring Method
A practical matrix usually scores likelihood and consequence separately, then combines them to produce an initial risk rating. Use plain definitions. For example, likelihood can range from rare to almost certain, while consequence can range from minor illness or limited contamination to serious occupational infection, laboratory-acquired disease or wider environmental release.
The initial rating should be based on the hazard before controls are considered. Then document existing controls and assess the residual risk. This distinction prevents a strong cabinet, good training or reliable vaccination policy from disguising a hazardous procedure. It also makes it easier to identify whether the proposed biosafety level is genuinely supported by the control system.
Useful factors include the infectious dose and organism characteristics, the likelihood of aerosol generation, the amount and concentration of material, the frequency of the activity, staff competency, equipment reliability and the possibility of exposure outside the primary containment device. Consider whether an aerosol could escape before it is captured, whether a process is open or closed, and whether the laboratory can respond effectively to a spill or failure.
A matrix should also record uncertainty. If the specimen concentration is unknown, a centrifuge seal has not been validated, or a new molecular platform is being introduced, rate the uncertainty explicitly. A conservative decision may be needed until evidence, validation or specialist advice reduces that uncertainty.
Connect The Matrix To Biosafety Level Decisions
Biosafety level determination should follow the risk assessment, not precede it. In Australia, terminology such as PC2 and PC3 describes physical containment expectations, while the actual decision also depends on activity, organism, equipment, procedures and institutional controls. A PC2 room cannot automatically make every TB procedure suitable for PC2 work, and a PC3 designation cannot compensate for weak procedures or poor maintenance.
The matrix can use a decision structure like the one below. The examples are broad prompts rather than universal classifications. Laboratories should compare them with current Australian requirements, their organisation’s biosafety advice and any jurisdiction-specific direction.
| Activity or condition | Main exposure concern | Controls to document | Escalation indicator |
|---|---|---|---|
| Receiving sealed primary specimens | Leakage, incorrect packaging or unexpected contamination | Trained staff, suitable reception area, inspection process, spill supplies and secure transport | Damaged container, visible leakage or uncertain packaging |
| Opening or aliquoting potentially infectious specimens | Aerosol or splash exposure | Validated biological safety cabinet, respiratory and eye protection as required, competency and decontamination procedures | Work cannot be completed reliably inside primary containment |
| Centrifugation or other aerosol-prone processing | Aerosol release during loading, unloading or equipment failure | Sealed rotors or safety cups, cabinet use where required, maintenance and incident response | Unsealed processing, failed containment or unknown equipment performance |
| Culture manipulation or work with concentrated organisms | High likelihood of infectious aerosol and contamination | Appropriate containment facility, validated methods, restricted access, specialist training and medical response arrangements | Procedures exceed facility capability or involve elevated organism concentration |
| Spill, breakage or instrument failure | Unplanned exposure and environmental contamination | Written response plan, appropriate disinfectant, exposure reporting and emergency contacts | Staff cannot safely contain, decontaminate or investigate the event |
| Referral or disposal of TB material | Exposure during movement or waste handling | Secure packaging, documented chain of custody, validated waste treatment and contractor controls | No verified route for safe transport, treatment or disposal |
Record the reason for the final containment decision in plain language. “PC3 required” is less useful than “PC3 required because concentrated viable cultures are manipulated in an open procedure with a credible aerosol pathway that cannot be controlled by the current PC2 arrangement.” The explanation should identify the evidence, assumptions and controls on which the decision depends.
The phase checklists can help laboratories link this assessment to broader quality activities, including facilities, equipment, personnel, documentation and assessment. That connection matters because containment is a system: a cabinet may be technically suitable, yet the overall risk remains unacceptable if certification, cleaning, training or incident reporting is unreliable.
Test The Controls In Real Conditions
Controls should be specific, observable and assigned to an owner. Engineering controls may include a correctly selected and maintained biological safety cabinet, sealed centrifuge systems, secure specimen storage and suitable ventilation. Administrative controls include competency assessment, access restrictions, preventive maintenance, specimen acceptance rules, exposure management and a clear process for suspending work when conditions are unsafe.
Personal protective equipment is important, but it should be treated as the final layer rather than the primary answer. The matrix should state what protection is required for each activity, how staff are trained to use it and what happens when an item is unavailable or damaged. Fit testing, facial hair considerations, laundering or disposal arrangements and replacement supplies may need attention, particularly in small services where procurement can take time.
Validation and observation are essential. Watch staff perform the task, confirm that the cabinet is used correctly, review centrifuge loading practices and test spill response through exercises. A process may look safe on paper but become risky when a busy bench is crowded, a courier arrives unexpectedly or a specimen is sent from a remote site in unsuitable packaging.
Australian context should be visible in the controls. A regional laboratory may need arrangements for after-hours advice, long-distance referral and limited access to specialist engineers. A service in a major city may have easier access to a public health reference laboratory, but still needs a safe local response while waiting for confirmation. Documenting these realities makes the matrix practical rather than generic.
Review Decisions And Keep Evidence
Risk assessments should be reviewed when the organism or procedure changes, a new instrument is installed, an incident occurs, staff report a near miss, a control fails or legislation and standards are updated. Schedule routine review as well; an annual review is a common minimum, with more frequent review for high-risk or rapidly changing work.
Maintain the evidence behind the decision. This may include cabinet certification, equipment maintenance records, competency results, validation reports, incident investigations, training attendance, waste contractor documentation and consultation notes. The downloadable materials provide a useful starting point for organising supporting documents and building a consistent quality record.
A strong matrix also shows who approved the decision and who can change it. Define escalation routes to the laboratory manager, institutional biosafety adviser, infection-control team and relevant public health authority. If the residual risk remains high, the correct action may be to pause the procedure, send the material to a suitably equipped laboratory or redesign the workflow.
Use the matrix as a living part of the quality management system. Begin with one TB workflow, test the scoring with the people doing the work, refine the controls and then extend the method to specimen reception, referral, culture, molecular testing and waste. A documented, locally realistic assessment gives Australian TB laboratories a defensible basis for containment decisions and safer everyday practice.